CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Charlotte, North Carolina, United States and 43 other locations
The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).The aims of this study are to see how safe an...
Phase 2
Charlotte, North Carolina, United States and 54 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Charlotte, North Carolina, United States and 123 other locations
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T Syst ...
Phase 2
Charlotte, North Carolina, United States and 23 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer i...
Phase 2
Huntersville, North Carolina, United States and 137 other locations
a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non Small Cell Lung...
Phase 3
Salisbury, North Carolina, United States and 168 other locations
This is a single-arm, single-stage Phase II study designed to evaluate the 1-year PFS rate in subjects with locally-advanced NSCLC (stage II/III) and...
Phase 2
Charlotte, North Carolina, United States
antitumor activity of STX-721 in participants with non-small cell lung cancer (NSCLC) carrying EGFR/HER2 exon 20 insertion (ex20ins...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 14 other locations
This study is open to adults 18 years and older with advanced or metastatic non-small cell lung cancer. People can join the study i ...
Phase 3
Rock Hill, South Carolina, United States and 140 other locations
This study will assess the efficacy and safety of the combination of ceralasertib and durvalumab versus standard of care docetaxel in patients with l...
Phase 3
Charlotte, North Carolina, United States and 190 other locations
Clinical trials
Research sites
Resources
Legal